Curcumin attenuates angiotensin II-induced abdominal aortic aneurysm by inhibition of inflammatory response and ERK signaling pathways

Evidence-based Complementary and Alternative Medicine

Volumn 2014, Issue , 2014, Pages

  Hao, QingQing ^a,b,c   Chen, Xu ^a,b   Wang, XiaoYu ^a,b   Dong, Bo ^a,b,d   Yang, ChuanHua ^d  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

^c SHANXI MEDICAL UNIVERSITY   (China)

^d AFFILIATED HOSPITAL OF SHANDONG UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; APOLIPOPROTEIN E; CURCUMIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MONOCYTE CHEMOTACTIC PROTEIN 1; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA;

ABDOMINAL AORTA; ABDOMINAL AORTA ANEURYSM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MALE; MINIOSMOTIC PUMP; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PUMP; TREATMENT DURATION; WESTERN BLOTTING;

EID: 84934891453     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2014/270930     Document Type: Article

References (27)

1. A. Daugherty, L. A. Cassis, and H. Lu, "Complex pathologies of angiotensin II-induced abdominal aortic aneurysms, " Journal of Zhejiang University: Science B, vol. 12, no. 8, pp. 624-628, 2011.
2. A. Daugherty, D. L. Rateri, and L. A. Cassis, "Role of the reninangiotensin system in the development of abdominal aortic aneurysms in animals and humans, " Annals of the New York Academy of Sciences, vol. 1085, pp. 82-91, 2006.
3. H. Lu, D. L. Rateri, L. A. Cassis, and A. Daugherty, "The role of the renin-angiotensin system in aortic aneurysmal diseases, " Current Hypertension Reports, vol. 10, no. 2, pp. 99-106, 2008.
4. H. Lu, D. L. Rateri, D. Bruemmer, L. A. Cassis, and A. Daugherty, "Involvement of the renin-angiotensin system in abdominal and thoracic aortic aneurysms, " Clinical Science, vol. 123, no. 9, pp. 531-543, 2012.
5. Y. Zhang, J. C. Naggar, C. M. Welzig et al., "Simvastatin inhibits angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein e-knockout mice: possible role of ERK, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 29, no. 11, pp. 1764-1771, 2009.
6. E. Sikora, G. Scapagnini, and M. Barbagallo, "Curcumin, inflammation, ageing and age-related diseases, " Immunity & Ageing, vol. 7, article 1, 2010.
7. Y. Sunagawa, H. Wada, H. Suzuki et al., "A novel drug delivery system of oral curcumin markedly improves efficacy of treatment for heart failure after myocardial infarction in rats, " Biological and Pharmaceutical Bulletin, vol. 35, no. 2, pp. 139- 144, 2012.
8. S. K. Jain, J. Rains, J. Croad, B. Larson, and K. Jones, "Curcumin supplementation lowers TNF-α, IL-6, IL-8, and MCP- 1 secretion in high glucose-treated cultured monocytes and blood levels of TNF-α, IL-6, MCP-1, glucose, and glycosylated hemoglobin in diabetic rats, " Antioxidants and Redox Signaling, vol. 11, no. 2, pp. 241-249, 2009.
9. J. L. Quiles, M.D. Mesa, C. L. Ramírez-Tortosa et al., "Curcuma longa extract supplementation reduces oxidative stress and attenuates aortic fatty streak development in rabbits, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 22, no. 7, pp. 1225-1231, 2002.
10. J. Fan, X. Li, Y.-W. Yan et al., "Curcumin attenuates rat thoracic aortic aneurysm formation by inhibition of the c-Jun Nterminal kinase pathway and apoptosis, " Nutrition, vol. 28, no. 10, pp. 1068-1074, 2012.
11. Y. Wang, S. Krishna, and J. Golledge, "The calcium chlorideinduced rodent model of abdominal aortic aneurysm, " Atherosclerosis, vol. 226, no. 1, pp. 29-39, 2013.
12. A.Daugherty, M.W.Manning, and L. A. Cassis, "Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice, "The Journal of Clinical Investigation, vol. 105, no. 11, pp. 1605-1612, 2000.
13. Z. S. Galis, M. Muszynski, G. K. Sukhova et al., "Cytokinestimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion, " Circulation Research, vol. 75, no. 1, pp. 181-189, 1994.
14. J. P. Habashi, J. J. Doyle, T.M. Holmet al., "Angiotensin II type 2 receptor signaling attenuates aortic aneurysm in mice through ERK antagonism, " Science, vol. 332, no. 6027, pp. 361-365, 2011.
15. A. Daugherty, M. W. Manning, and L. A. Cassis, "Antagonism of AT2 receptors augments Angiotensin II-induced abdominal aortic aneurysms and atherosclerosis, " British Journal of Pharmacology, vol. 134, no. 4, pp. 865-870, 2001.
16. F. E. Parodi, D. Mao, T. L. Ennis, M. B. Pagano, and R. W. Thompson, "Oral administration of diferuloylmethane (curcumin) suppresses proinflammatory cytokines and destructive connective tissue remodeling in experimental abdominal aortic aneurysms, " Annals of Vascular Surgery, vol. 20, no. 3, pp. 360- 368, 2006.
17. X. Zhang, Y. H. Shen, and S. A. LeMaire, "Thoracic aortic dissection: Are matrix metalloproteinases involved?" Vascular, vol. 17, no. 3, pp. 147-157, 2009.
18. F. Aziz and H. Kuivaniemi, "Role of matrix metalloproteinase inhibitors in preventing abdominal aortic aneurysm, " Annals of Vascular Surgery, vol. 21, no. 3, pp. 392-401, 2007.
19. H. Takagi, H. Manabe, N. Kawai, S.-N. Goto, and T. Umemoto, "Circulating matrix metalloproteinase-9 concentrations and abdominal aortic aneurysm presence: A meta-analysis, " Interactive Cardiovascular and Thoracic Surgery, vol. 9, no. 3, pp. 437- 440, 2009.
20. X. Zhu, Z. Wang, C. Hu, Z. Li, and J. Hu, "Honokiol suppresses TNF-α-induced migration and matrix metalloproteinase expression by blocking NF-κB activation via the ERK signaling pathway in rat aortic smooth muscle cells, " Acta Histochemica, vol. 116, no. 4, pp. 588-595, 2014.
21. I. Parastatidis, D. Weiss, G. Joseph, and W. R. Taylor, "Overexpression of catalase in vascular smooth muscle cells prevents the formation of abdominal aortic aneurysms, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 33, no. 10, pp. 2389-2396, 2013.
22. C. Aivatidi, G. Vourliotakis, S. Georgopoulos, F. Sigala, E. Bastounis, and E. Papalambros, "Oxidative stress during abdominal aortic aneurysm repair-biomarkers and antioxidant's protective effect: A review, " European Review for Medical and Pharmacological Sciences, vol. 15, no. 3, pp. 245-252, 2011.
23. R. M. Starke, N. Chalouhi, M. S. Ali et al., "The role of oxidative stress in cerebral aneurysm formation and rupture, " Current Neurovascular Research, vol. 10, no. 3, pp. 247-255, 2013.
24. M. Cohen, A. Meisser, L. Haenggeli, and P. Bischof, "Involvement of MAPK pathway in TNF-α-induced MMP-9 expression in human trophoblastic cells, " Molecular Human Reproduction, vol. 12, no. 4, pp. 225-232, 2006.
25. T. Saito, Y. Hasegawa, Y. Ishigaki et al., "Importance of endothelialNF-κB signalling in vascular remodelling and aortic aneurysm formation, " Cardiovascular Research, vol. 97, no. 1, pp. 106-114, 2013.
26. S.Mito, K.Watanabe, M. Harima et al., "Curcumin ameliorates cardiac inflammation in rats with autoimmune myocarditis, " Biological and Pharmaceutical Bulletin, vol. 34, no. 7, pp. 974-979, 2011.
27. V. Soetikno, F. R. Sari, V. Sukumaran et al., "Curcumin prevents diabetic cardiomyopathy in streptozotocin-induced diabetic rats: possible involvement of PKC-MAPK signaling pathway, " European Journal of Pharmaceutical Sciences, vol. 47, no. 3, pp. 604-614, 2012.